IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancerNadine Bley, Stefan Hüttelmaier, Annekatrin Schott et al.|RNA Biology|2020Cited by 55
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist’s Decision on Systemic Therapy in a Real-World SettingRamona Erber, Arndt Hartmann, Ágnes Bánkfalvi et al.|International Journal of Molecular Sciences|2022Cited by 13
IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancerNadine Bley, Stefan Hüttelmaier, Annekatrin Schott et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 7